token,frequency
table,29
the fiscal year,116
the transition,6
period,22
name,3
registrant,1
chartercommissionfile,1
par,4
value,37
share,41
check,8
mark,8
the registrant,10
a wellknown seasoned issuer,1
oindicate,3
pursuant,15
section,9
such filing,1
no oindicate,2
this chapter,2
disclosure,13
herein,5
definitive proxy,1
information,35
reference,70
any amendment,1
filer,6
a nonaccelerated filer,1
reporting,13
company,13
growthcompany,1
growth,28
Ã¾,1
o,1
the extended transition,1
a shell,1
aggregate,1
market,39
stock,55
the closing,2
price,42
such stock,1
number,3
common stock,68
the following document,1
this report,9
annual meeting,2
refer,1
corporationamerisourcebergen,1
global pharmaceutical sourcing,3
distribution,36
patient access,3
patient care,2
the effectiveness,9
efficiency,8
the pharmaceutical supply,10
chain,13
animal health,9
acomprehensive offering,1
brandname,11
specialty,16
home,4
healthcare,37
suppliesand,1
equipment,20
a wide variety,4
acute care,5
health,21
order,11
care,17
site,4
dialysis,5
an assortment,1
research,9
pharmaceutical consulting,1
niche,1
premium,9
inventory,12
management,34
pharmacy,10
automation,2
solutionsindustry,1
an independent thirdparty,1
provider,13
the pharmaceuticaland,1
industry,13
a compound,1
annual growth,1
rate,53
the growth,4
isdependent,1
part,30
pharmaceutical manufacturer,1
increasesin,1
addition,31
the pharmaceutical industry,4
the number,10
age,1
rapidlygrowing segment,1
the population,4
this age,1
group,13
the rest,1
asubstantial portion,1
total healthcare,1
development,5
the advent,1
new research,1
production,25
biotechnology,7
gene,1
therapy,3
delivery,8
other specialty,5
the continued growth,2
emphasis,2
other thirdparty,1
utilization,3
growthwe,1
the increase,18
generic usage,1
a favorable trend,1
gross profit,20
marginopportunity,1
revenue,51
approximately0,2
the prescription,1
volume,2
response,8
cost,22
containment,1
the use,5
efficient drug,1
national attention,1
the overall increase,1
drug,20
a beneficial impact,1
prolonged hospital,1
overall healthcare,1
anddevelopment,1
introduction,1
costeffective drug,1
the federal government,1
major health,1
reform,5
legislation,7
access,8
a portion,8
prescription,10
the health,1
reformlaw,1
reimbursement,21
the healthcare,5
enforcement authority,1
fraud,13
abuse,6
pharmaceuticaland,2
medical device,1
the healthreform legislation,1
page,10
certain risk,2
business,84
diverse network,1
ofdistribution,2
service,18
pharmaceutical distribution,11
typicallythe primary supplier,1
a broad range,4
the efficiency,2
effectiveness,6
the delivery,4
channelstrategyour,1
strategy,3
the global pharmaceutical supply,1
channel,9
valueadded distribution,1
globalcommercialization,1
patient,4
focused strategy,1
a seamlessand,1
unified way,1
operating,41
the execution,1
strategyoptimize,1
size,3
andmarket,1
breadth,1
capital,20
position,19
competitiveness,1
a leader,1
community,2
plasma,4
other blood,4
support,12
the new biotechnology,1
the near futurewith,1
the genericmarketplace,1
generic product,2
private label,1
program,25
source,6
a valueadded genericformulary program,1
compliance,16
dataand,1
manufacturer,10
international presence,1
globalmanufacturer,1
commercialization,4
strategywe,1
offer,1
theirpatient,1
assistance,2
rapid new product,1
marketing,4
product,11
logistical supportour,1
independent community,4
pharmaceutical benefit,1
merchandising,1
network,2
retail pharmacy,1
the country,1
andprivate label,1
hospital,1
packaging,6
institutional andretail,1
robust distribution,1
facility,35
a national distribution,1
center,5
a single shipping,1
destination,1
productivity,2
income,99
weinvest,1
warehouse,2
technology,13
adopt,1
operatingleverage,1
fullservice,1
pharmaceuticaldistribution,1
businessesoptimize,1
contract,14
field,1
patientassistance,1
mitigation,1
other market,1
global specialty,4
transportation,4
the biopharmaceutical industry,4
platform,2
the introduction,4
ourspecialty,1
the companion,1
animal,6
avariety,2
ecommerce,1
fulfillment inventory,1
managementsystem,1
procurement,1
consultation,1
special order,1
fulfillment,1
core,3
willcontinue,1
an independent regional distributor,2
the northeast region,1
ofindependent,1
future animal health,1
customersin,1
independent pharmaceutical wholesaler,2
fullline distribution,2
brand,12
generic,2
highvalue,2
manufacturersand,1
pharmaceuticalwholesaler,1
a joint venture,2
strategic focus,1
certain noncore,1
time,47
additional divestituresoperationsoperating,1
structure,4
reportable segment,24
the purpose,7
drugdistribution,1
strategic global sourcing,1
a comprehensive offering,3
acute,3
mail,6
longterm care,5
a number,18
a variety,9
disease,3
providespharmacy management,1
staffing,3
additional consulting,3
software,5
retail healthcare,4
providersotherother,2
global commercialization,2
a full suite,3
integrated manufacturer,3
clinical trial,3
toproduct,3
postapproval,3
transportationand,1
feed,3
both thecompanion,1
force,4
the majority,3
geographic focus,1
type,1
customer,23
national account,1
close coordination,1
local distribution,1
theirrespective product,1
an enterprisewide marketing,1
all other marketing,1
a diverse customer,1
base,3
pharmaceutical manufacturersinstitutional,1
other alternate,1
physician group,1
regional retaildrugstore,2
mass,2
typicallythe primary source,1
supply,3
overthecounter product,1
beauty,1
aid,1
the operating,5
ofhealthcare,1
the loss,13
any majorcustomer,1
relationship,6
future revenue,1
cash,89
none,3
the fiscalyear,6
a supplier,1
the primary source,1
a majority,2
fiscal year,16
purchasesinformation,1
segment,9
primary enterprise,1
resource,1
planning,1
electronic order,1
entry,1
invoice preparation,1
purchasing,3
segmentsoperate,1
the ability,8
segments0,1
entitywide infrastructure,1
environment,2
speed,1
advanced information,1
example,5
an effort,1
other supply,1
custody,2
andpharmaceutical compounding,1
profitability,7
securesupply,1
a platform,1
demand,4
replenishment,1
singlesource,1
thirdparty,8
claimsprocessing,1
realtime price,1
incentive,2
a substantial portion,1
purchase,10
electronic interface,1
systemswhich,1
transactional volume,1
the warehouse,1
leveragea,1
significant portion,1
providerscompetitionwe,1
competitive global environment,1
the distribution,10
withinpharmaceutical distribution,1
ownwarehousing,1
deliverycredit,1
use,7
the principal,1
the course,1
the subject,3
registrationwe,1
other intellectual property,1
theconduct,1
such intellectual property,1
acombination,1
trade,21
secret patent,1
copyright,1
confidentiality,1
protectionswe,1
hold,1
relate,1
automated pharmacy,1
medication,1
certain warehousing,1
proprietary packaging,1
protection,4
proprietary intellectual property,1
the intellectual property,1
infringement,1
collective bargaining,2
other such bargaining,1
connection,35
the negotiation,1
the expiration,4
adequate contingency,1
place,4
the eventof,1
any such disruptions0,1
extensive oversight,1
state,44
federaland,1
storage,2
andor distribution,1
various security,2
comply,2
the sale,7
holdingand,1
outsourcing,3
current good manufacturing,3
activecommunication,2
the ongoing compliance,3
commercial distribution,4
an initial meeting,6
potential resolution,6
a consent,12
decree,9
necessary see,4
regard,9
the possible entry,2
decreewe,1
the federal antikickback,1
statute,2
receiving,2
any remuneration,2
the purchasing,1
leasing,1
lease,4
arrange,1
any way,2
other federal healthcare,1
the submission,1
payment,13
the government,5
the case,5
the fraud,1
scope,1
the safety,2
the pharmaceutical supplychannel,1
counterfeit,1
thedistribution,2
system,8
the federal level,2
the supply,7
security,15
law,8
federal traceability,2
the lot,2
level,3
pedigree,1
an electronic interoperable prescription,2
traceability,1
licensing,3
comparable state,1
wholesale distributor,1
anew category,1
no assurance,13
withadditional related state,1
any failure,2
suspension,6
delay,2
the cost,4
operationsfederal insurance,2
toexpand,1
insurance,6
coverage,7
a combination,4
an expansion,1
ofmedicaid,1
the formula,2
federal upper payment,2
retail community,1
a nationwide basis,2
the weighted averagemanufacturer,1
implementing,1
branded prescription,1
actual acquisition,1
prescription drug,2
statemedicaid,1
programsas,1
a result,20
scrutiny,2
tocontinue,1
the state,1
this process,3
additional legislation,1
andor,15
regulation,6
the production,3
the structure,2
the present healthcare,1
the interpretationsof,1
significant0,1
the discontinuation,1
ability,18
a material adverse effect,11
financial condition,13
various federal state,2
respect,24
anddisposal,1
laboratory,1
practicesthe,1
the failure,4
a significant impact,3
financial conditionsee,1
risk,14
a discussion,1
otherlitigation,1
failure,9
andfinancial conditionhealth,1
forth privacy,1
the privacy,1
the security,1
protected health,3
maintain,2
andor access,1
theirlocation,1
the manner,1
violation,1
complianceprogram,1
andreinvestment,1
federal privacy,1
privacy,5
new notification,1
final rule,1
enforcement,3
act,1
the meaning,2
other personal information,1
sensitive personal information,1
such information,1
personallyidentifiable information,1
applicable privacy,1
website,4
the website,1
charge,8
investoramerisourcebergencom,1
discussion,3
these risk,1
tothose,1
forth,3
pricing,17
generic pharmaceutical launchesin,1
an unfavorable brand,1
generic pharmaceutical pricing,2
profit,17
consolidated operating,1
a material,6
adverse effect,2
the purchase,6
wholesaleacquisition,1
the reference,2
pricein,1
list,3
the value,1
ofour,1
inflation,5
deflation,3
certain distribution,1
a price,4
appreciation,3
component,1
gross profitfrom,1
fluctuation,1
the timing,7
extent,1
the frequency,2
generic pharmaceutical price,2
the policy,1
voluntary manufacturer,1
the negative impacton,1
a decline,3
thepast,1
operationscompetition,1
consolidation,24
profitas,1
detail,1
competitive inaddition,1
the impact,18
power,2
pressure,2
pharmaceutical compounding,3
andstate,1
the pharmaceutical distribution,2
andpharmacy,1
diversion,5
counterfeitadulterated andor,1
the risk,4
various federal andstate,1
various state,3
recent yearssome,1
burden,1
pharmaceutical compoundingat,1
all supplychain,1
drugtraceability,1
a category,1
additional related state,1
compliancemoreover,1
draft,1
final guidance,1
the requirementsin,1
other chain,1
andcompounding,1
contracting,4
the methodology,1
pricingcontracting,1
discounting,1
occasion,1
certain brand,2
the scope,1
continuingimplementation,1
every aspect,1
the law,1
multiple source,3
retailcommunity,1
calculate,1
ofthe,1
weighted average,1
average manufacturer,1
toimplement payment,1
the actual acquisition,1
the final rule,1
prior reimbursement,1
theimpact,1
reduction,3
multisource,1
cause,1
profitabilitythe,1
rebate,6
minimum,2
the rebate,1
line,1
single source,1
innovator,1
oral solid dosage,1
form,3
federal government,3
the future,10
impact,3
an adverse impact,3
onour,1
the potential impact,1
inreimbursement,1
related reporting,1
outpatientprescription,1
apositive impact,1
enactmenton,1
guidance,4
flexibility,1
indication,1
business0,1
oncology,3
private practice,1
underhospital prime vendor,1
this trend,1
inthe future,1
theability,1
discount,5
policy,7
the rate,2
usand,1
a request,3
a final rule,1
outpatient hospital,1
rule,2
the addon payment,1
new separatelypayable part,1
data,2
first quarter,3
hospital outpatient,1
prospective system,1
a potential innovation,1
model,8
privatesector,1
prior authorization,1
step,1
spending,1
instance,1
the sequestration,1
provision,12
cut,1
plan,27
this time,2
an adverse effect,3
the context,1
advance,1
notice,1
certain price,1
increase,3
those price,1
a blueprint,1
a wide range,1
competition,3
outofpocket,1
negotiation,2
congressional approval,1
governmentdrug price,1
businessif,1
the federalgovernment,1
other governmenthealthcare,1
andabuse,1
the referral,1
apatient,1
treatment,2
the ordering,1
other governmentsponsoredhealthcare,1
give federal enforcement,1
funding,1
powersand,1
inconnection,5
judicial authority,1
a manner,1
programs0,1
concern,1
the abuse,3
regulatory action,1
businesscertain,1
governmental,2
local governmental,1
a significantnumber,1
the diversionof,1
accordance,26
anintent,1
control,9
toidentify,1
review,1
engage,1
significantdue diligence,1
monitoring,1
ourbusiness,1
harm,2
reputation,8
an early stage,1
the adverse resolution,1
the misuse,1
effect,10
annual assessment,1
an assessment,3
tax,149
the assessment,4
calculation,1
other state,2
enact legislation,1
such legislation,2
the aggregate,3
financial conditionour,2
legal proceedingswe,1
the dispensing,2
andthe provision,1
antitrust class,1
action,4
commercial employment,1
environmental intellectual property,1
the above,2
factor,1
disruptiveto ordinary business,1
the defense,1
the marketing,4
sale,8
the provision,4
administrative liability,1
possible exclusion,1
participation,2
judgment,5
fine,1
the basis,2
qui,2
tam,4
the qui,1
civilfalse,1
a private person,2
a relator,3
behalf,6
governmentsunder,1
the filing,3
a qui tam,1
complaint,2
government,10
the action,2
dispensing,2
brandandor,1
seal,2
the applicable court,1
qui tam,1
any health,1
the litigation,1
any portion,1
administrative action,1
a fiveyear term,2
other penalties0,1
renewal,3
a significant customer,5
top ten,1
contractwith,1
such customer,2
the customer,8
tothe extent,1
such early termination,1
the contract,1
subject toexpiration,1
each year,2
renew renegotiate,1
any significant customer,1
expiration,2
date,17
flowsthe,1
realizedin,1
strategic arrangement,1
agreement,10
arrangement,9
acquisition,10
expectation,1
servicesarrangement,2
the potential,2
innovation,1
toachieve,1
the arrangement,1
an ongoing basis,1
issubject,1
the potential inability,1
potential benefitsresulting,1
improved generic drug,1
inability,1
generic manufacturersor,1
the potential disruption,1
the duration,1
any disruption,1
flow,10
stockholdersin,1
any reduction,1
financial flexibility,1
potential,1
supplier,3
the transaction,1
the overall strategic relationship,1
towork,1
an efficient,1
effective manner,1
furtherance,1
the relationshipin,1
the right,6
the obligation,5
the public market,1
commonstock,6
common stockwe,1
collaboration,1
andthe diversion,1
attention,1
the anticipated time,1
frame,1
a material adverse impact,2
financialcondition,1
operationsa disruption,1
generic purchasing,1
financial resultswe,1
the primary distributor,1
generic pharmaceutical program,1
the genericspurchasing,1
any reason,2
natural disaster,1
labor,1
disruptionregulatory,1
governmental action,1
an obligation,1
credit,57
termination,1
possible revocation,1
substance,1
pharmaciestax legislation,1
financial conditionwe,1
a large corporation,1
theus federal state,1
the repeal,1
lastinfirstout,1
oureffective tax,1
historical tax,1
precedent,1
federal state,3
foreign tax,2
relevant tax,1
authoritiesor,1
taxlaw,1
corporate tax,2
international tax,2
the interpretation,1
thereof,1
the ambiguity,1
the subjectivity,1
thecomplexity,1
the geographic mix,1
any particular period,1
the period,13
madethe suspension,1
revocation,2
compound,1
store,1
distribute,1
the refusal,1
any such facility,1
any enforcement action,1
other litigation,1
governingdistribution,1
thecompounding,1
andoperating,1
compliancewith various security,1
the illegal diversion,2
a regulatory agency,1
tribunal,1
broad enforcement,2
ithe ability,1
ii seize,1
recall,3
iii,1
a civil complaint,1
pharmedium,4
subsidiarywe,1
other authority,1
agency,1
correspondence,1
timely manner,1
effort,2
andcan result,1
the assertion,2
the commencement,2
civil criminal,1
the suspension,5
amaterial adverse effect,1
applicable current gmp,1
subsequent enforcement,1
acquisition0,1
the business,3
a warning,1
letter,1
the inspection,1
headquarters,1
the sufficiencyor,1
timing,2
meeting,1
the agencys,1
largest0b,1
thememphis facility,1
the remediation,1
active communication,4
theconsumer,2
thepossible entry,2
several state,1
temporary licensing,1
the status,5
our0b,1
these state,1
an adverseimpact,1
operationsa failure,1
regulatory authority,1
a failure,4
warning,1
letterand,1
operationan enforcement action,1
license revocation,1
operationsthe,1
labelingor,1
death,3
reputational harmthe,1
labeling,2
hospitaloutpatient,1
ambulatory,1
surgery,1
the injury,1
a patient,1
quality,4
issuesmanufacturing,1
flaws improper packaging,1
human,1
other errorany,1
a recall,1
safety,2
the ordinary course,4
retrieval,1
negative publicity,1
publicity,1
a quality,1
issue,1
accurate,1
inaccurate,1
acceptance,1
decrease,5
result,2
liability,16
a classor,1
multidistrict litigation,1
such action,1
litigation,38
reputational harm,1
patient harm,2
a competitor,1
a hospital pharmacy,1
future insurance,1
insufficient,1
any liability,1
ofinsurance,1
a reasonable cost,1
anyliability,1
any particular time,2
ofassessment discussion,1
makepublic disclosure,1
regulations0,1
operational experience,1
ormore,2
the near orlong term,1
the assumption,1
the fair value,32
the imposition,1
adequate,1
the integration,2
portfolio,1
an asset,1
a business,3
difficulty,1
alternative exit,1
the achievement,1
a divestiture,1
antibribery anticorruption,1
international trade,2
businessfinancial position,1
operationswe,1
weare,1
subject,16
export,2
sanction,1
similar anticorruption,1
any violation,1
substantial liability,1
a loss,10
ofreputation,1
the market,4
favorable treatment,1
an adequate system,1
disgorgement,1
ordebarment,1
foreign government,2
international business,1
timeconsumingand,1
an adverse outcome,2
any such investigation,2
audit,7
financial position,2
global operationsour,1
ofacquisition,1
recession,1
currency,5
volatility,7
uncertainty,4
foreign policy,1
a particular location,1
money,3
operationsour stock,1
financial market,2
the capital,4
significant disruption,1
movement,1
material,2
ourability,1
disruption,4
liquidity,1
businessour,1
the bankruptcy,4
insolvency,6
other credit,3
a significant customermost,1
ourassessment,1
analysis,5
creditworthiness,2
a security,1
interest,55
creditexposure,1
the position,1
andcredit,1
the solvency,2
any customer,1
a substantial amount,1
adverseeffect,1
receivable,7
rise,1
any supplier,1
a time,1
the supplier,3
a substantial account,1
payable balance,1
sophisticated information,2
process analyze,1
manage,1
anddistribution,1
numerous distribution,1
process,3
ship,1
a timely basis,1
otherproduct,1
the accurate billing,1
limited toautomation,1
offering,1
online,1
a significant portion,3
the extent,6
a thirdparty,1
the information,3
third partiesinformation,1
the proliferation,1
sophisticationand,1
cyber,3
breach,2
the disclosure,3
misuse,1
confidential orproprietary information,1
the continueddevelopment,1
enhancement,1
attack,1
damage,1
a priority,1
robust information,1
any information,1
the international transfer,2
that regulate,1
thecollection,1
transfer,4
the transfer,4
these foreign dataprivacy,1
collection,1
businessand,1
financial positionour,1
goodwill,15
a significant charge,2
accounting,16
principlesus,1
impairment,14
anannual basis,1
potential impairment exist,1
performance,12
relativeto,1
significant negative industry,1
a significant decline,1
capitalization,2
asustained period,1
a change,1
divestiture,2
asset,7
to0,1
a rise,1
the accuracy,2
validity,2
any impairment,1
ourgoodwill,1
such charge,1
insurancethe occurrence,1
financial performance,1
physical damage,1
partial closure,1
longterm disruption,2
climate,1
change,2
energy,2
the regulatory andother,1
the availability,5
nature,1
occur,1
combination,1
depend,1
the amount,19
a decrease,9
ourprofitability,1
the general economy,1
discretionary spending,1
bad debt,3
expense,73
office,4
warehousespace,1
a robust distribution,1
comprise,1
satisfactory conditionitem,1
following,4
a list,2
executive,4
experience,1
yearsmr,2
the company,64
yearsms,1
executive leadership,1
tomay,1
toapril,1
the trading,1
symbol,1
were0 record,1
board,20
the quarterly dividend,3
ourboard,1
dividend,3
quarterly cash,2
thefuture,1
the payment,9
amount,12
the discretion,3
other factorscomputershare,1
agent,2
co,1
telephone,1
the total number,2
the average price,1
ofpublicly,1
the approximate dollar,1
each month,2
the fiscal,2
a share,9
repurchase program,10
a total,7
this program,8
availability,7
a new share,4
graph,1
year,13
cumulative total,1
stockholder,1
the performance,2
an index,1
peer,1
the graph,2
the common stock,4
thenew,1
represent fiscal yearend,1
index,3
the last trading,1
day,3
eachfiscal quarter,1
inwholesale pharmaceutical distribution,1
reinvestment,1
dividends0,1
conjunction,3
thereto,21
loss,29
common share,1
net,42
0total debt,2
equity,23
employee,17
severance,26
benefit,31
goodwillimpairment,2
no income,4
expense net,8
a0,1
a noncustomer note,3
gain,17
antitrust litigation,18
net ofincome tax,2
early retirement,7
debt,27
ofexpense,1
assessment,16
of0,6
employeeseverance,1
pension,5
settlement,16
taxbenefit,1
chargeon,1
an equity,1
investment,6
million0,1
hereinwe,1
biotech,1
serviceswe provide,1
separate reportable segment,1
reportablesegment,2
softwareto,2
institutional healthcare,2
the companionanimal,2
summary,5
the prior fiscal year,44
the revenue,4
a leading pharmaceutical wholesaler,2
offset,7
a lowercontribution,1
execution,3
the specialty,17
joint venture,16
bylower,1
the current fiscal year,14
anincrease,3
lastin,1
firstout,4
comparison,7
the prior fiscal yeardistribution,1
selling,10
the duplicate,2
the implementation,5
new information,3
new informationtechnology,1
systemsoperating income,1
the decrease,7
incurred significant litigation,1
an increase,18
andadministration,1
the current fiscal yearour,1
effective tax,14
thefiscal year,5
the effect,2
total incometax benefit,1
a reduction,4
inthe,6
federal income,5
the fourth quarter,9
aportion,1
legal settlement,3
the federal corporate tax,2
the effective tax,2
nondeductible legal settlement,2
the benefitfrom,1
option,12
andnet income,1
the prior fiscal year0,1
the year,7
percentage,2
the midsingle,1
future,2
new innovative brand,1
the likely increase,1
conversion,1
pricedeflation,1
the industry,1
pharmaceuticalmanufacturer,1
downward pressure,1
other thirdparty reimbursement,1
regulationsrevenue,1
primary,2
segmentthe,1
overall market,2
strong oncology product,1
groupa number,1
flowsgross,1
remediation,11
ingross profit,1
amaterial impact,1
generic deflation,2
genericinventory,1
the prior fiscal yearafter,1
compoundingfacility,1
this production,1
impacted grossprofit,1
a consent decreenew,1
the ratableshare,2
each licensee,2
the initial payment,2
calendar,5
an estimate,5
the periodfrom,1
contribution,8
apercentage,1
margin,9
basis,44
the priorfiscal year,3
a percentage,12
grossprofit,1
the decline,1
consulting,1
groupwe,1
changedistribution,2
amortization,13
thespecialty,3
ofrevenue distribution,1
point0,1
property,5
infrastructure,2
various technology,3
theamortization,2
transformation,7
acquisitionrelated deal,7
integration,5
initiativesemployee severance,1
organization,4
impairment charge,1
unit,18
annual goodwill,2
total segment,3
costsnew,1
inoperating,1
a startup venture,2
the respective weighted average interest,2
issuance,10
ofprofarmas debt,1
related interest,1
the prior fiscal yearour,2
cashin,1
fair,3
foreign currency,8
the remeasurement,5
the early retirement,5
see,10
the debt,1
millionprepayment,1
an unamortized debt,1
unamortized debt,1
costsour,1
total income,1
ratereduction,1
the effectivetax,1
the benefit,2
vestingnet income,1
the prior fiscal yearyear,1
segment0,1
the retail customer,1
strong growth,2
companionanimal,1
programsgross,1
other offset,1
assurance,1
patient safety,1
an increasein revenue,1
lowerprice appreciation,1
margingross,1
andmwi,1
the priorfiscal yearwe,1
respectivelyoperating,1
total,2
was0,1
point,2
decline,2
ofrevenue,1
the second half,1
acrossmany,1
certain administrative functions0,1
millionemployee severance,1
millioncharge,1
the settlement,9
andintegration,2
intangiblesamortization,1
ingross,1
the prior year,1
the gross profit,1
expenses0,1
financing,10
construction,2
inaverage,1
compensation,15
the receipt,1
private letter,1
ruling,1
an income,3
deduction,3
exercisenet income,1
a material impact,7
financialposition,2
past experience,1
the application,3
a complete list,1
significant accounting,1
policiessee,1
net ofan,1
allowance,15
an allowance,2
return,6
full value,2
full credit,3
thetime,2
historical customer,1
the allowance,2
millionand,3
respectivelyin,1
the appropriate allowance,1
the aging,2
receivablesindustry,1
financial strength,1
standing,2
default,2
history,2
othersmay lead,1
the calculation,2
the required allowance,2
the ultimate realization,2
probable bad debt,2
historical experience,3
specific credit,2
collectability,2
each business,1
theallowance,1
a consistent manner,1
the bad debt,1
forany period,1
end,3
other adjustmentsbad debt,1
respectivelyan increase,1
respectivelyschedule,1
a rollforward,1
doubtful accountsbusiness,1
the acquisition,10
fair value,30
the residual,2
thepurchase price,1
thirdparty appraisal,1
historical experienceand,1
the management,1
future cash,1
forimpairment,2
a qualitative assessment,2
likely thannot,2
the qualitative assessment,2
the goodwill,4
the current year,3
qualitative annual assessment,1
future periodsthe,2
impairment test,6
the reporting,7
thefair value,2
no further evaluation,2
no impairment loss,2
the fair valuethe,2
difference,2
an impairment loss,2
the total amount,2
a particularoperating,2
the nature,1
regulatory environment,3
an incomebased approach,2
the exception,3
publiclytraded stock,3
the incomebased approach,2
a discounted cash,4
an appropriate discount,2
thatmarket,1
a sale,1
transaction,8
the annual goodwillimpairment,1
test,4
depreciationamortization capital,1
longrange,2
the discount,5
theoverall aftertax rate,1
a market,2
participant,2
weighted average cost,2
both debt,2
a riskpremium,1
available information,2
actual future,2
future impairment,2
overall methodology,2
a comparison,2
the fairvalue,2
the indefinitelived intangible asset,2
the asset,7
the relief,6
royalty,6
method,18
valuation,6
technique,1
the discounted cash,2
trademarksand,1
a royalty,2
usewe,1
required annual impairment,2
a goodwill impairment,3
a recoverability,4
undiscounted cash,6
the recoverability,5
future periodswe,1
recoverability,2
the existence,2
ofan,2
impairment indicator,2
activity,3
animpairment indicator,1
ofresumed production,1
uncertain tax,4
tobe,1
financial reporting,41
net operating,2
purposeswe,1
a valuation,3
certain deferred tax,1
the required valuation,1
application,1
the valuation,4
weanticipate,1
the other deferred income,1
abovewe prepare,1
file,1
interpretation,1
record,2
the normal course,2
examination,3
infuture,1
lawresulting,1
court,1
applyingcomplex tax,1
the tax,7
an uncertain taxposition,1
the taxing,2
the positionwe,1
deferred tax,13
reasonable judgment,1
a different estimate,1
resolution,3
the amountsaccruedthe,1
the preceding,1
paragraphs,1
the ultimate effective tax,1
a complete discussion,1
the variable interest,2
financial interest,2
aninvestment,2
this evaluation,2
the date,17
initial investment,2
theinvestment,1
an investment,4
a variable interest,2
entity,5
the power,2
an entity,2
the entitys economicperformance,1
an entitys,2
the voting,2
anownership interest,3
noncontrolling interest,4
financial statementswe,1
ownership,7
the equity,2
otherthantemporary impairment,1
a component,3
that determination,2
no impairment,1
subpoenas government,1
investigationsand,1
antitrust commercial environmental product,3
intellectual property,3
regulatory employment,1
discrimination,2
a liability,4
the materiality,2
aloss,1
excess,5
an additional loss,2
areasonable possibility,1
contingency,2
the likelihood,2
a reasonable estimate,2
the range,2
the firstin,2
currentreplacement,1
mix,2
aredifficult,1
provision0,1
the multicurrency,1
securitization,8
note,8
the overdraft,1
facilityin,1
total fixedrate debt,1
total variablerate debt,1
sufficient capital,1
outstanding debt,1
primary ongoing cash,1
fund,4
the repayment,3
routine growth,1
expansionthrough new business,1
requirementsas,1
dollar,1
this cash,1
further assessment,1
no additional taximpact,1
a onetime transition,5
general corporate purposeswe,1
build,1
balance,2
shortterm capital,1
intraperiod,1
shortterm working capital,1
cumulative intraperiod,1
tomake,2
the principal0,1
an effective yield,4
the principal amount,3
weredue,1
prepayment,2
multicurrency,2
senior unsecured revolving,2
a syndicate,2
an amendment,3
the maturity,4
indebtedness,4
borrowingsunder,1
rating,4
pointsover,2
the alternate base,2
canadian prime rate,2
the total commitment,2
any time,4
includingcompliance,1
a financial leverage,3
ratio,3
saleswith,1
a commercial paper,2
an aggregate amount,2
the program,2
bearing,2
a discount,2
the commercial paper,3
capacity,4
commercial paper,3
an accordion,2
feature,2
thecommitment,1
lender,2
approval,2
thedecember,2
shortterm commercial paper,2
a program,2
fee,2
acustomary unused fee,1
the capacity,1
a revolving basis,2
a whollyowned special purpose,2
turn,2
receivables,2
theservicer,2
additional receivables,2
tothe maximum,2
the facility,4
a financing,2
vehicle,2
an attractive interest,1
relative toother,1
sourceswe,1
an uncommitted unsecured line,2
a principal amount,1
the bank,2
prior notice,2
overdraft,2
shortterm normal trading,1
cycle,1
businessin,1
variablerate term,4
loan,6
the scheduled repayment,4
principal payment,4
maturity,4
a rate,6
a base,10
amargin,1
a margin,9
the margin,4
public debt,2
pointsto,1
a scheduled principal payment,2
0million,4
bearsinterest,1
the cash,3
consideration,2
a new variablerate term,2
pointsthe,1
arrearswe,1
the nonrecourse shortterm,1
longterm debt,6
such debt,1
thereon,2
thecapital stock,1
subsidiariesin,1
sharerepurchase,1
a financial institution,2
the initialpayment,2
funded stock,2
holdback,2
the financial institution,2
the volumeweighted average price,2
the term,3
duringthe,1
authorization,2
the right topurchase,1
a minority,2
assumingtheir exercise,1
an exercise,6
a sixmonth period,3
b,5
a strategy,2
the dilutive effect,3
exercise,5
special share,3
a special share,2
repurchase,3
theybecame,1
the sixmonth period,1
cashthe,1
a summary,3
ournoncancelable operating,1
the portion,2
future minimum lease,2
the accounting,4
owner,2
the financing,3
obligation,4
noncash termination,2
the financingobligationthe,1
ourliability,1
asixyear period,1
commitment,5
the above tablewe,1
outsource,1
the above tableour,1
this liability,1
anestimate,1
theamount,1
any future cash,1
reasonable certainty,1
the result,5
net income,7
a legalsettlement,1
plus interest,2
theresult,1
deferred incometax benefit,1
depreciation,6
the deferred income,1
reformdeterioration,1
hand,2
an annual average,1
the day,1
the week,1
the month,1
a gradual change,2
customerour,1
ofincome tax,1
ofinterest,1
merchandise,4
deferred income,3
a litigation,2
accrual,1
a contract,1
amendment,2
ourrelationship,1
volumecapital,1
significant capital,1
upgradingour information,1
the development,1
trackandtrace,1
theexpansion,1
a northeast regional animal,1
distributor,1
a leading national provider,2
billionnet,1
theissuance,1
senior notesnet cash,1
repayment,1
common stocknet,1
theexercise,1
the exercise,3
programwe,1
quarterly dividend,1
increasesdividend,1
anticipate,2
other factorsmarket,1
exposure,6
fixedrate andvariablerate debt,1
variablerate debt,4
variable interest,2
rateshowever,1
the unfavorable impact,1
a hypothetical decrease,1
the favorable impact,1
annual net interest,1
minimal exposure,1
exchange,5
foreign exchange,2
twopercent,1
consolidated revenue,1
trading,1
oneforeign currency,1
the foreign currency,2
outstanding note0 table,1
thisreport,1
likely outlook,1
forecast,1
intend plan,1
synergyon track,1
seek estimate,1
future performance,1
incorrect,1
frequency,1
deflationcompetition,1
pharmaceutical market,1
the diversion,1
public concern,1
opioid medicationsprosecution,1
suit,2
shareholder,1
federal scrutiny,1
qui tam litigation,1
costsmaterial adverse resolution,1
the retention,1
key customer,1
theadverse resolution,1
any contract,1
other dispute,1
supplier payment,1
thestrategic longterm,1
the pharmaceuticaldistribution,1
the global generic,1
adverse resolution,1
regulatory orenforcement action,1
continued suspension,1
foreign expansion,1
noncompliance,1
antibribery,1
import,1
financial marketvolatility,1
bankruptcy,2
a major customer,1
theloss,2
a major supplier,1
mix malfunction,1
the impairment,1
a charge,2
the inability,1
the expected time,1
the fact,1
the disruption,1
other economic business,1
competitive legal tax,1
i,2
ii,3
iv,2
v,2
significant market,1
the price,1
thecompanys common stock,1
herein0,1
consolidated balance,1
comprehensive income,6
financial statement,1
schedule,3
the index,1
opinion,3
thefinancial position,1
conformity,2
principleswe,1
internal control,26
framework,1
report,3
anunqualified opinion,1
thereonbasis,2
the responsibility,1
responsibility,2
an opinion,2
audits,2
a public accounting,2
firm,3
the audit,4
obtainreasonable assurance,2
material misstatement,2
performing,2
a test,1
evidence,1
the overall presentation,1
a reasonable basis,2
s,4
auditor,1
doubtful accounts0,1
0total property,1
accumulated depreciation,1
paidin capital,1
other comprehensive loss,2
attributable,3
consolidated financial statements0,4
translation,5
adjustment net,1
other comprehensive income,1
stockpurchase,3
repurchase transaction,1
torestricted share,3
repurchasetransaction,1
0provision,1
noncustomer note,1
other loan,2
beginning,1
hasa,1
bothhealthcare,1
animal healthbasis,1
the consolidated financial position,1
all intercompany,1
consolidationthe preparation,1
the preparation,4
continued reasonableness,1
all income,1
the income,3
statement,2
an employer,1
withholding,1
liabilityaccounting,1
a policy,1
election,1
annual reporting,3
the quarter,4
a cumulative adjustment,1
the establishment,1
a deferred tax,5
unrecognized tax,5
presentation,2
the excess tax,1
prospectivelyin,1
recognition,2
industryspecific guidance,1
a single comprehensive model,1
forrevenue,1
principle,2
a company,1
an amount,3
the consideration,1
the entity,1
the effective date,2
yearin,1
versus,1
principal versus,1
no 0 revenue,1
the guidance,2
evaluation,1
a modified retrospective basis,1
the adoption,1
animmaterial impact,1
operationsor cash,1
flows0,1
transparency,1
andcomparability,1
the balance,3
sheet,4
key information,1
a modified retrospective application,1
theadoption,2
standard,1
this new accounting,1
flowsat,1
this standard,1
the first quarter,2
adoptionbusiness,1
acquisitioncash,1
ofcash,1
a large number,1
other alternatecare,1
the financialcondition,1
thehealthcare,1
industrythe,1
receivable net,1
second largestcustomer,1
collateral,1
theultimate realization,1
financial conditionand,1
a consistentmanner,1
reputable credit,1
thereforebear minimal credit,1
tomitigate,1
the investment,4
equivalentscontingenciesloss,1
governmentsubpoenas government,1
intellectual propertyregulatory employment,1
a losscould,1
a reasonable possibility,1
ofthe loss,1
uponthe receipt,1
a recovery,1
the antitrust litigation,1
designationand,1
tradingpurposesthe company,1
the functional currency,1
the applicable local currency,1
the current exchange,1
the weighted average exchange,1
thecompany,5
the qualitative annual assessment,1
thenature,1
ofwhich,1
flowanalysis,1
each reporting,1
a saletransaction,1
the annual goodwill,1
revenuegrowth,1
the overall aftertax rate,1
a risk,1
conditions0,1
unchangedthe impairment test,1
the impairment testing,1
techniquefor,1
annual impairment test,1
and0,4
intangible asset,1
the straightline,3
arecoverability assessment,1
inmemphis,1
tennessee,1
thatthe suspension,1
an impairment indicator,1
a recoverabilityassessment,1
resumed production,1
a method,1
the need,1
some portion,1
the deferred tax,1
an uncertain tax,1
uponexamination,1
the positiontax,1
the recognition,2
probableoutcome,1
full disclosure,1
a tax,2
examinationinvestment,1
marketable debt,4
the appropriateclassification,1
the time,5
each balance,1
marketabledebt,1
either shortterm,1
longterm,1
contractual maturity,1
shortterm,1
inthe current period,1
the specific identification,1
financialinterest,1
ifthe structure,1
impact theentitys economic performance,1
an ownership,1
consolidated financial statementsthe,1
significant influence,1
an impairment charge,1
acomponent,1
the construction,1
the owner,1
regardless,1
the significance,1
project,2
a corresponding financingobligation,1
completion,1
a saleleaseback,1
therelated financing,1
continuinginvolvement,1
the related financing,1
the life,1
the lease term,1
an operating,2
leaseand,1
the related lease,1
a straightline basis,3
theexpected lease term,1
the related inventorymerchandise,1
the lastin,1
inventoryvaluation,1
current replacement,1
machinery,1
maintenance,2
computer,1
internal use,1
the projectreach,1
stage,1
preliminary stage,1
all other postimplementationstage,1
useful liveswhich range,1
persuasive evidence,1
an arrangement,1
renderedthe price,1
the accompanying,1
other customer,1
incentivesthe,1
returnedto,1
the gross dollar,1
bulk,2
the express direction,1
drop,1
crossdock,2
immediate shipment,1
a principal,1
the primary obligor,1
contractual responsibility,1
fulfillment andacceptability,1
full risk,1
the creditworthiness,1
any bulk,1
any year,1
the compensation,1
a binomial option,2
restricted stock,16
the grant,4
the requisite service,4
the same line,1
item,1
associatedwith,1
nonvested performance,3
periodic assessment,2
the probability,2
itsestimate,2
issuedthe income,1
benefitsfrom,1
pick pack,1
andadministrative,1
various price,1
these reserve,1
the judgment,1
the specific incentive,1
other pertinent information,1
a continual basis,1
appropriate,1
the ultimate outcome,1
any outstanding claim,1
thecompanys estimate0 table,1
a binomial lattice,1
andthe,1
the vesting period,1
the end,5
an adjustment,1
the statement,1
hadbeen,1
full see,1
certain purchase,1
adjustmentspharmedium,1
reportable segmentthe purchase,2
the acquisitionthe purchase,1
the net tangible,4
the fair valueof,1
receivable inventory,5
the acquiredsoftware,1
useful life,4
purposesnevscoin,1
a final workingcapital,1
adjustment,2
the northeastregion,1
tocurrent,1
future animal,1
segmentthe purchase,1
the preliminary allocation,3
the finalization,7
capitaland income,1
account,4
the final fair,4
deductiblefor income,1
purposeshd,1
a final working,1
capitaladjustment,1
the issuance,4
new longterm debt,1
independentpharmaceutical wholesaler,1
itsstrategic scale,1
a tradename,1
thetradename,1
incometax purposesprofarma,1
a noncontrolling ownership,1
the brazilian marketplace,1
joint,1
venturethe,1
the additional investment,1
receivedsubstantial governance,1
majority,1
an additional investment,2
other respectivelythe,1
the noncontrolling interest,1
an agreedupon,1
the preliminaryallocation,1
shortterm debt,2
a noncontrollinginterest,1
the consolidation,1
taxpurposesthe,1
the incremental ownership,1
incometax,1
jointventure,1
theconsolidation,1
purposesin,1
these represent level,1
a pretax loss,1
interest0,1
this investment,1
obtainedsubstantial governance,1
economic performance,1
isnot,1
future financial support,1
recourse,1
the general credit,1
foreign income,2
current provision,1
deferred benefit,1
reconciliation,2
the effective income,1
rate0,3
local income,1
federal tax,1
benefit0,1
compensation0,1
reform0,1
distribution0,1
staff,3
a registrant,1
the necessary information,1
reasonable detail,2
certain income,4
the measurement period,1
a companysaccounting,1
that measurement period,1
the enactment,1
registrantsunder,1
i measurement,1
complete ii measurement,1
estimatedand iii measurement,1
measurement,2
the followinga,1
ratechange,1
a deferred income,1
a lowerus federal income,1
a current income,1
on0,1
provisional transition,1
the fourthquarter,1
foreign cash,2
a sixyear period,2
the measurement,2
the fiscal quarter,8
furtherassessment,1
no additional tax,1
reinvesteddeferred income,1
the future tax,1
0capital loss,1
carryforward,1
potential tax,3
fromfederal net operating,1
foreign net operating,2
varyingexpiration,1
federal alternative minimum tax,1
foreign alternative minimum tax,1
the utilization,1
this decrease,1
offsetin part,1
the additional valuation,1
certain state,2
the addition,1
foreign net operatingloss,1
this amount,1
ofemployee,2
no tax,1
future periodsincome tax,1
respectivelythe,1
federal jurisdiction,1
the aggregate tax,1
taxreturn,1
federal benefit,1
theunrecognized tax,1
the beginning,2
asfollows fiscal year,1
anuncertain,1
civil litigation,1
reserve,1
this reserve,2
a payment,2
millionplus interest,1
this litigation,1
uncertaintax position,1
millionother,1
assuccessor,1
that time,1
a fair value,1
the approximate tax,1
deductible amount,1
the 0year term,1
any value,1
the initial fair value,1
onthe date,1
a private letter,1
aresult,2
the estimatedbenefit,1
this tax,1
benefitadjustment,1
the total fair value,1
respective exercise,2
millionan additional tax,1
the change,1
anestimated purchase,1
measurementthe,1
thereafter0,1
total debt,1
current portion,2
nonrecourse current portion,1
total net,1
foreign subsidiariesinterest,1
from0 basis,1
rateand,1
borrowing,1
a customary unused fee,1
an attractive interestrate,1
relative,1
other financing,1
noninterest bearing,1
a principal amountnot,1
shortterm normaltrading cycle,1
businessterm,1
equal eitherto,1
the public debt,2
wascompliant,1
pari passu,1
the stated interest,1
the table,1
additional indebtedness,1
the repurchase,1
preferred stock,8
creation,1
certain corporate actssuch,1
an additional covenant,1
the shortterm,1
subsidiariesother,1
thereafterinterest,1
the above indebtedness,1
respectivelytotal amortization,1
the accretion,1
original issue,1
authorized capital,1
series,1
asotherwise,1
the board,7
no voting,1
the respective series,1
the same dividend,1
vote,1
the exclusive right,1
a per,1
directorsfrom,1
purchaseprogram,1
tocomplete,1
billionof,1
theright,1
thecompanys,4
open market,2
issuanceof,1
an aggregate,3
exercisable duringa sixmonth period,1
thecompanys treasury,1
a firstin,2
firstout basis,2
a reissuance,2
millionin,1
the sixmonthperiod,1
treasury,1
stock0,1
the weighted average number,2
attributable toamerisourcebergen,1
corporation,4
restrictedstock,1
outstanding fiscal year,1
dilutive stock,1
respectivelynote,3
outstanding common stock,1
a related party,1
a pharmaceutical distribution,1
an agreement,2
favorable economic pricing,1
a generic purchasing,1
ofseptember,1
various retirement,1
a deferred compensation,1
eligible employeesthe compensation,1
theadministration,1
retirement,1
other benefit,1
an internal committee,1
senior finance,1
performanceof,1
the termination,2
a salaried defined benefit,1
regulatory approval,1
theplan,1
the combination,1
andthe purchase,1
a nonparticipating annuity,1
the plan,5
a pension,2
the relateddeferred tax,1
assets0,1
the surplus,1
a defined contribution,1
regular compensation,1
the participant,5
an additional discretionary contribution,1
the salaried defined benefit,1
eligible calendar,1
anexpense,1
a discretionary contribution,1
no discretionary contribution,1
the direction,1
the employee,2
servicethe,1
this unfunded plan,2
keymanagement,1
total cash,3
the annual compensation,3
limit,3
this plan,2
an annual amount,2
hercompensation,1
key management,1
annualcompensation,1
equivalentsare,1
fractional number,1
the average,1
ofcommon stock,1
each full share,1
underthe deferred compensation,1
deferred compensation,1
the granting,2
nonqualified stock,1
the fair market,3
the option,1
grant,5
afouryear service,1
expire,2
director,2
a threeyear service,1
nonemployee director,1
theamerisourcebergen,1
thehistorical volatility,1
implied market,1
historical exercise,1
takinginto,1
yield,1
curve,1
grantthe,1
yield0,1
common stock0,1
life,1
the above valuation,1
sharebased compensation,3
respectivelya,4
related information,1
ispresented belowin,1
contractual term,1
intrinsic value,1
belowin,1
expected future compensation,2
is0,1
a weighted average period,2
the product,1
yearsperformance,1
certain executive,1
represent common stock,1
the futureperformance,1
a threeyear performance,1
achievement,1
specific performance,1
the target,2
award,3
awardsgranted beginning,1
recognizedperformance,1
target,1
amountsin,1
the threeyear performance,1
salary,2
the fairmarket,1
the stock,1
the last business,2
each sixmonth purchase,1
the stockon,1
each sixmonth period,1
each participant,1
each calendar,1
the open market,1
forissuance,1
the0,1
an expense,1
rental expense,1
noncancelable operating,1
minimum lease,1
thecompanys commitment,1
relating,3
surplus,1
dispute,1
the organization,1
a period,2
the form,1
a lumpsum paymentlitigation,1
defined benefit,1
certain disputed itemsother,1
regulatory employmentdiscrimination,1
a reserve,2
range,1
other outcome,1
any subsequent reporting,1
the outcome,1
trial,2
conduct,1
the impositionof corporate integrity,1
criminal penaltiesgovernment,1
promotion,1
the qui tam,1
localcivil,1
the federal stateand,1
the relator,1
a confidential basis,1
the complaint,3
the court,1
the participation,2
mayseek,1
a civil penalty,1
each purported false claim,1
forpayment,1
the investigation,1
orsettlement,1
consumer,1
lawseither,1
a government,1
investigation,1
collateral litigation,1
class,3
third party,1
lawssubpoenas,1
various government,1
a customer,1
other industry,1
acooperative manner,1
these mattersare,1
subsidiary,5
the prefilled syringeprogram,1
certain oncology,1
a plea,1
a guilty plea,1
a onecount,1
strictliability,1
misdemeanor,1
the agreement,2
a total criminal fine,1
forfeiture,1
the guilty plea,1
the federal criminalinvestigation,1
register,1
withthe,1
principlewith,1
entirety,1
fiscal quarter,1
potentialadministrative action,1
dismissal,2
prejudice,3
the maintenance,3
a compliance,1
an independent review,1
a financialrecoupment program,1
thecivil litigation,1
any admission,1
the reserve,1
matter,2
the manufacturer,2
that product,1
any state,1
the authority,1
a subpoena,3
billing,1
a grand jury,3
subpoena,3
the laboratory,1
a certain type,1
syringe,1
illegitimate,1
individualswho abuse,1
other equitable relief,1
this matter,1
express denial,1
any wrongdoing,1
theyear,1
significant number,1
a subsidiary,1
adefendant,1
opioid,3
pain,2
putative class,1
federalstate,1
controlled substance,2
common law,1
public nuisance,1
unjust enrichment,1
seek,1
equitable relief,1
monetary damagesafter,1
a motion,1
a hearing,1
an initial group,1
amotion,1
a friend,1
an order,1
track,1
dispositive motion,1
practice,2
discovery,3
certain bellwether,2
fact,3
the bellwether,1
certain public nuisance,1
thatthe majority,1
the suit,1
courtordered settlement,1
proceedingsaside,1
intent,1
a position,1
the likely outcome,1
this request,1
fromgovernment,1
connectionwith,2
the matter,1
grand jury,2
testimony,1
additional information,1
an administrative subpoena,1
dialogue,1
ofmichigan,1
the subpoena,1
theusaonj,1
tothe,2
subpoenassince,1
industrial purposesas,1
general information,1
a pharmaceutical manufacturer,1
the process,1
consolidatedstatement,1
similar legislation,1
financial conditionthe,1
the compounding,1
pharmaceutical productsthe,1
thefda,1
includingwith regard,1
the possible entry0,1
an enforcement action,1
license revocationnote,1
a plaintiff,1
these class,2
a member,1
the class,1
the past,1
attorney,1
separate reportable segmentdisclosure,1
onglobal commercialization,1
chief,1
decision,1
maker,1
whosefunction,1
providersabcs,1
the elimination,1
expensecredit,1
expense employeeseverance,1
corporate office,1
each operatingsegment,1
performanceafter,1
itslargest,1
atpharmedium,1
possible entry,1
the suspended production,1
applicable toall,1
stability,1
resourcesthe,1
expensethe,1
0total capital,1
shortterm nature,1
had0,1
the money,1
inputsthe,1
the corresponding fair value,2
the recorded amount,1
inputs0,1
administrative expensesdepreciation,2
include,2
the third quarter,1
includepharmedium,1
estimate,1
the second quarter,2
a noncustomernote,1
discrete income,1
other b,1
0operating income,1
respectivelybthe third quarter,1
a regular quarterlycash dividend,1
that information,2
disclosuresthe,1
such term,1
theexchange,1
theperiod,1
maintainingadequate internal control,1
reasonable assurance,7
the reliability,4
andthe preparation,1
internal controlover,1
pertain,2
preparation,2
withus,1
prevention,2
timely detection,2
unauthorized acquisition,2
disposition,2
a material effect,2
the financial statementsbecause,1
anyevaluation,2
the degree ofcompliance,1
this assessment management,1
permittedby,1
interpretive guidance,1
thecompanys internal control,2
oftotal revenue,1
public accounting,1
an attestation,1
all material respectseffective internal control,1
criteriaas,1
audit ofinternal control,1
an evaluation,1
the internal control,1
an unqualified opinion,1
effective internal control,2
theeffectiveness,4
all material respectsour,1
an understanding,1
weakness,1
the design,3
opiniondefinition,1
a process,1
financialreporting,1
companysinternal control,1
provide,2
the companys,1
thefinancial statementsbecause,1
the degreeof,1
herein byreference,1
the closeof,1
the fiscal yearinformation,1
this reportwe,1
copy,1
anyprovision,1
websiteitem,1
referenceitem,2
reference0,1
the following,1
the following financial statement,1
toitem,1
the applicable accounting,1
bythe,1
toexhibit,8
trustee,10
exhibit,10
onmarch,4
forthe fiscal quarter,1
thefiscal quarter,2
byreference,8
theregistrant,3
originator,3
buyer,5
party,21
seller,13
servicer,5
the variouspurchaser,1
administrator,7
amongamerisource,4
thepurchaser,4
purchaser,1
the purchaser,4
asadministrator,2
assignee,2
byand,1
onform,1
asperformance,1
guarantor,3
favor,1
recipient,1
theborrowing,1
the borrowing,2
administrative agent,4
partythereto,3
datedas,1
theamendment,1
andrestatement,1
any security,1
holder,1
the reasonable cost,1
reproductioneach,1
a management,1
a compensatory,1
a director,1
executive officer,1
the undersigned thereunto,1
duly,1
atbeginningof,1
atend,1
thousand,2
respectively0,1
consent,1
the incorporation,1
forthe year,1
certification,4
knowledge,5
any untrue statement,2
a material fact,2
omit,2
light,2
other financial information,2
thefinancial condition,2
officer,4
defined inexchange,2
such disclosure,4
supervision,2
toensure,2
material information,2
prepared b,2
such internal control,4
oursupervision,2
such evaluation,2
d,2
any change,2
mostrecent fiscal quarter,2
fourth fiscal quarter,2
an annual report,2
recent evaluation,2
committee,2
operation,2
summarize,2
financial information,2
a significant role,2
internalcontrol,2
myknowledge,1
all material,2
the financial condition,2
ofmy,1
request,1
this certification,1
is a wellknown seasoned issuer,1
Ã¾ no oindicate,2
posted pursuant,1
contained herein,1
accelerated filer,4
emerging growthcompany,1
emerging growth,2
reporting company,1
use the extended transition,1
is a shell,1
Ã¾the aggregate,1
voting stock,1
improve patient access,3
enhance patient care,2
increase the effectiveness,2
distribute acomprehensive offering,1
including acute care,1
mail order,1
alternate site,3
reimbursementand pharmaceutical consulting,1
andpackaging solutionsindustry,1
impact the growth,1
ongoing research,2
continued growth,1
used brandname,1
increased emphasis,1
managed care,2
consider the increase,1
reduce revenue,1
rising healthcare,1
adopted cost,1
encourage the use,1
believe drug,1
had a beneficial impact,1
continued emphasis,1
continuing introduction,1
existing drug,1
enacted major health,1
expand access,1
increased the number,1
costs the health,1
including drug,2
expanded disclosure,1
enhanced enforcement authority,1
prevent fraud,1
are typicallythe primary supplier,1
offer a broad range,2
enhance the efficiency,1
improve the delivery,2
provide valueadded distribution,1
pharmacies health,1
increase channel,1
improve patient outcomes,1
disciplined focused strategy,1
grow revenue,1
increase operating,1
improve the efficiency,1
allowing the pharmaceutical supply,1
deliver healthcare,1
are a leader,1
serviceand support,1
offer a valueadded genericformulary program,1
provide dataand,1
include assistance,1
enables independent community,1
connectsour retail pharmacy,1
purchasing andprivate label,1
networkincludes a national distribution,1
increased productivity,1
operating income,15
implement warehouse,1
increase operatingleverage,1
increasing volume,1
consulting service,1
supporting access,1
staffing patientassistance,1
copay assistance,1
risk mitigation,1
leading global specialty,4
established platform,1
doing business,1
was an independent regional distributor,2
provides fullline distribution,2
leading pharmaceuticalwholesaler,1
provide specialty,2
divested certain noncore,1
consider additional divestituresoperationsoperating,1
requireseparate reportable segment,1
provide drugdistribution,1
reduce healthcare,1
improve patient outcomesthe,1
distributes a comprehensive offering,3
overthecounter healthcare,3
including acute,3
including plasma,3
supply management,3
provides a full suite,3
leading animal health,3
micro feed,3
marketing the majority,1
has support,1
serve national account,1
receiving service,1
have an enterprisewide marketing,1
have a diverse customer,1
include acute care,2
are typicallythe primary source,1
enhance the operating,1
affect future revenue,1
be the primary source,1
operating segmentsoperate,1
operating segments0,1
drive efficiency,1
automated warehouse,1
regulate the pharmaceutical supply,2
strengthen customer,1
reduce operating,1
providing a platform,1
including product,2
billing thirdparty,1
processes a substantial portion,1
operating systemswhich,1
manage the majority,1
thirdparty service,1
related healthcare,1
include price,1
valueadded service,1
are the subject,1
processes software,1
facilitate theconduct,1
protect such intellectual property,1
imposed protectionswe,1
dispensing equipment,1
seekpatent protection,1
assert infringement,1
existing collective bargaining,1
have adequate contingency,1
assure delivery,1
compounding purchase,1
meet various security,2
governing the sale,2
compounding packaging,1
including the ability,2
regarding the ongoing compliance,2
resume commercial distribution,2
outsourcing facility,2
voluntarilysuspended production,1
had an initial meeting,6
todiscuss potential resolution,2
is necessary see,4
including the federal antikickback,1
offering receiving,2
paying any remuneration,2
induce the purchasing,1
purchase lease,1
causing the submission,1
protect the safety,2
prevent the introduction,1
became law,3
establishes federal traceability,2
including licensing,1
licensed thirdparty,2
governing wholesale distributor,1
achieve compliance,2
be no assurance,13
increase the cost,1
intended toexpand,1
including coverage,1
reforms an expansion,1
changed the formula,2
formultiple source,1
require state,2
apply payment,1
reduce prescription drug,1
expected tocontinue,1
governing the production,1
have a material adverse effect,9
continueto purchase,1
handling anddisposal,1
have a significant impact,2
set forth privacy,1
protect the privacy,1
collect maintain,2
strengthened federal privacy,1
governing protected health,1
imposed new notification,1
including sensitive personal information,1
protecting such information,1
complywith applicable privacy,1
agdpr compliance,1
following discussion,2
describes certain risk,1
set forth elsewhere,1
experience an unfavorable brand,1
have a material,3
use wholesaleacquisition,1
sell brand,1
announced price,1
have a price,1
accelerates the negative impacton,1
increasing consolidation,1
bargaining power,1
including state,1
regulate the pharmaceutical distribution,1
prevent diversion,1
include operating,1
require all supplychain,1
issue draft,1
implement the requirementsin,1
reimbursement pricing,1
declining reimbursement,2
reducing reimbursement,1
changing the methodology,1
regulating pricingcontracting,1
been the subject,1
affecting reimbursement,1
given the scope,1
predict the impact,2
increase minimum,1
increased the rebate,1
drugsthe federal government,2
have an adverse impact,2
mitigate the potential impact,1
increased the use,1
had apositive impact,1
issued guidance,1
provide flexibility,1
implement indication,1
restrict coverage,1
nothave an adverse impact,1
sell specialty,1
caused a number,1
increase inthe future,1
reduce the rate,1
issued a request,1
include prescription drug,1
published a final rule,1
proposed rule,2
allow healthcare,1
implement prior authorization,1
have an adverse effect,2
affecting drug,1
provide advance,1
report information,1
outlines a wide range,1
improve competition lower,1
enhance negotiation,1
require congressional approval,1
healthcare fraud,2
involving healthcare,1
induce the referral,1
impose a number,1
designated health,1
increased funding,1
suspected fraud,1
offered inconnection,1
including the loss,1
regarding the distribution,4
indicated anintent,1
diversion control,1
ongoing monitoring,1
affect ourbusiness,1
theoutcome the adverse resolution,1
address the misuse,1
considering legislation,1
pay an assessment,1
mitigate the impact,1
mayhave a material adverse effect,1
including the distribution,1
involvinghealthcare fraud,1
form the basis,1
complaints the qui,1
authorize a private person,1
acts the filing,1
has a fiveyear term,2
lose a significant customer,1
existing contractwith,1
expiration tothe extent,1
extend renew renegotiate,1
be realizedin,1
provides avariety,1
negotiating acquisition,1
continued cost,1
purchasing servicesarrangement,2
exploring innovation together,1
needed toachieve,1
including the potential inability,1
realize andor,1
realizing potential benefitsresulting,1
including improved generic drug,1
expected the potential disruption,1
extended the duration,1
including any disruption,1
return value,2
continue towork collaboratively,1
has the right,2
prevailing market,5
decreased revenue,1
have a material adverse impact,2
are the primary distributor,1
have an obligation,1
existing distribution,1
are a large corporation,1
existing precedent,1
includes a broad range,2
regarding the geographic mix,1
be madethe suspension,1
purchase compound,1
regulate the distribution,1
andpreventing the illegal diversion,1
ensure compliance,1
have broad enforcement,2
including ithe ability,1
filing a civil complaint,1
ordermonitoring program,1
detect the illegal diversion,1
require time,2
have amaterial adverse effect,1
enforce compliance,1
received a warning,1
following the inspection,1
consider the agencys,1
suspended production,9
resumed commercial distribution,1
resumes commercial distribution,1
address the remediation,1
resumecommercial distribution,1
requested information,1
concerning the status,1
have an adverseimpact,1
including a failure,2
andor license revocation,1
freestanding hospitaloutpatient,1
are a number,1
including quality,1
labeling flaws improper packaging,1
regarding a quality,1
reducemarket acceptance,1
represent a classor,1
establish multidistrict litigation,1
any such action,1
prove insufficient,1
cover any liability,1
increasing cost,1
maintain insurance,1
obtain insurance,1
satisfy anyliability,1
integrateas part,1
lack operational experience,1
including litigation,1
risks the fair value,1
pending the imposition,1
encounter difficulty,1
delay the achievement,1
conduct business,2
create substantial liability,1
cause a loss,2
retaining business abroad,1
obtaining favorable treatment,1
maintain an adequate system,1
receive export,1
including inflation,1
disruptionif the capital,1
experience significant disruption,1
experiencedownward movement,1
be material,1
existing credit,1
obtain a security,1
affect the solvency,2
has a substantial amount,1
give rise,1
has a substantial account,1
facilitate the purchase,1
receive process,1
manage the accurate billing,1
ordering system,1
formanaging a significant portion,1
increased sophisticationand,1
orunauthorized access,1
remain a priority,1
have robust information,1
remediate any information,1
record a significant charge,2
earningsin accordance,1
accepted accounting,10
thecarrying value,1
considered a change,1
carrying value,18
affect the accuracy,2
andor disruption,1
andthe pharmaceutical distribution,1
affect the availability,1
existing insurance,1
provide protection,1
do business,2
affect the amount,1
cause a decrease,2
including interest,2
obtain credit,2
reduce discretionary spending,1
incur bad debt,1
has a robust distribution,1
is a list,2
joining the company,1
held management,1
increased the quarterly dividend,3
pay quarterly cash,2
forth the total number,1
purchased the average price,1
authorized a share,6
allowing the company,5
authorized a new share,4
including reinvestment,1
estimated assessment,2
contained hereinwe,1
increasethe effectiveness,1
require separate reportable segment,1
provides pharmaceutical distribution,2
provides pharmacy,2
pending execution,3
ongoing compliance,3
discuss potential resolution,4
consulting group,3
aswe incurred significant litigation,1
vesting andnet income,1
includingbiosimilars the likely increase,1
increased downward pressure,1
increased revenue,2
including group,1
expiration each year,1
maylose a significant customer,1
existing contract,1
have amaterial impact,1
ratably source,2
consolidationof the specialty,1
consulting business,2
restructuring initiativesemployee severance,1
needs litigation,2
ourbusiness transformation effortswe,1
excluding gain,2
facilityoperating income,1
invested cashin,1
held equity,4
andlegal settlement,1
enhance product,1
abovementioned contract,1
improve operating,4
ourbusiness transformation,1
benefit pension,1
defined contribution,4
acquisitionrelated intangiblesamortization,1
expense employee,1
efficiencyoperating income,1
operating expenses0,1
leased construction,1
involve accounting,1
have a material impact,7
require the use,1
presented net ofan,1
estimated customer,3
trends the allowance,1
determining the appropriate allowance,1
consider a combination,1
requires judgment,2
ongoing credit,2
forth a rollforward,1
engage thirdparty appraisal,1
assist management,1
require management,1
expected future cash,1
tested forimpairment,2
perform a qualitative assessment,2
performing the qualitative assessment,2
performthe qualitative annual assessment,1
carrying amount,2
exceeds the fair valuethe,2
exceed the total amount ofgoodwill,2
include the nature,1
utilize an incomebased approach,1
estimated control,2
forecasted cash,2
determine the fair value,4
reporting unit,2
believe thatmarket,1
use a discounted cash,2
make a number,2
working capital,8
is an estimate,2
includes both debt,1
including a riskpremium,1
recorded goodwill,2
changing business,2
remainedunchangedthe impairment test,1
testing date,1
estimate the fair value,1
using the relief,2
believe the relief,1
used valuation,2
indefinitelived trademarksand,1
pay a royalty,2
recorded a goodwill impairment,3
performed a recoverability,3
theforecasted undiscounted cash,2
perform the recoverability,4
perform a recoverability,1
compounding facility,3
represented animpairment indicator,1
excluding goodwill,1
established a valuation,1
described abovewe prepare,1
result infuture,1
recognize the tax,1
applying reasonable judgment,1
develop a different estimate,1
change an increase,1
havecaused income,1
controlling financial interest,2
is a variable interest,2
impact the entitys economicperformance,1
absorb an entitys,2
hold anownership interest,1
ourconsolidated financial statementswe generally,1
be otherthantemporary impairment,1
including antitrust commercial environmental product,3
record a liability,1
perform an assessment,1
provide disclosure,1
assesswhether a reasonable estimate,1
used the firstin,2
approximates currentreplacement,1
including availability,1
revolving credit,8
thereceivables securitization,1
generated cash,1
haveprovided sufficient capital,1
fund capital,1
ongoing cash,1
reinvest this cash,1
mayrequire the use,1
fund shortterm capital,1
cover shortterm working capital,1
securitization facility,1
elected tomake,2
have an effective yield,4
finance the early retirement,2
including the payment,2
finance the acquisition,2
extend the maturity,2
maintain the availability,4
have a commercial paper,1
bear interest,2
borrowing capacity,1
pay acustomary unused fee,1
weutilized the capacity,1
bears interest,5
sells a percentage,2
is theservicer,2
collected additional receivables,2
use the facility,1
offers an attractive interest,1
have an uncommitted unsecured line,1
fund shortterm normal trading,1
andas a result,1
required principal payment,3
made a scheduled principal payment as,2
totaling 0million,1
scheduled principal payment,1
finance a portion,1
issuing a new variablerate term,2
consolidated the nonrecourse shortterm,1
programduring the fiscal year,1
granted the right topurchase,1
diluted basis,2
commenced a strategy,2
mitigate the dilutive effect,2
is a summary,3
be the accounting,2
exclude the future,2
requires a onetime transition,3
services a significant portion,2
remaining commitment,2
represents anestimate,1
estimated liability,1
provided cash,2
suppliers the increase,1
statements the increase,1
was theresult,1
affect the number,1
changesin the ability,1
was the result,2
operating cash,3
extended the term,1
support the increase,1
included technology,1
expanding distribution,2
initiativesin the fiscal year,1
acquired a northeast regional animal,1
consolidated inconnection,1
included the early retirement,1
used a portion,1
fund a portion,1
following quarterly dividend,1
remainwithin the discretion,1
have market,2
manage interest,1
using a combination,1
have minimal exposure,1
utilize foreign currency,1
had oneforeign currency,1
denominated contract,2
hedges the foreign currency,2
expect likely outlook,1
project intend plan,1
sustain synergyon track,1
believe seek estimate,1
prove incorrect,1
increasing pressure,1
impactprescription drug,1
regarding the pharmaceutical supply,1
increased public concern,1
including shareholder,1
increased federal scrutiny,1
including qui tam litigation,1
governing the marketing,1
including continued suspension,1
managing foreign expansion,1
including noncompliance,1
controlincluding the integration,1
related thereto,1
divestitures the disruption,1
set forth,2
changing interest,1
accompanying consolidated balance,1
expressed anunqualified opinion,1
are the responsibility,1
express an opinion,2
are a public accounting,2
perform the audit,2
evaluating the accounting,1
evaluating the overall presentation,1
provide a reasonable basis,1
0noncontrolling interest,1
related torestricted share,3
accelerated share,1
reconcile net income,1
net cash,1
restricted share,1
helping bothhealthcare,1
enhance patient,1
present the consolidated financial position,1
indicated all intercompany,1
requires management,1
requires all income,1
allows an employer,1
triggering liabilityaccounting,1
make a policy,1
supersedes the revenue,1
andmost industryspecific guidance,1
outlines a single comprehensive model,1
recognize revenue,1
depict the transfer,1
reflects the consideration,1
deferred the effective date,1
clarifies the implementation,1
issuedasu no 0 revenue,1
whichamends the guidance,1
identifying performance,1
had animmaterial impact,1
increase transparency,1
regarding lease,1
accounting standard,1
toevaluate the impact,1
adopting this new accounting,1
estimate the impact,1
adopt this standard,1
issued accounting,1
acquired business,1
be cash,1
veterinarians the financialcondition,1
require collateral,1
considers a combination,1
financialstrength credit,1
accounts the calculation,1
maintains cash,1
exceed the amount,1
monitoring the risk,1
seeks tomitigate,1
monitoring the investment,1
resolve the company,2
records a liability,1
performs an assessment,1
provides disclosure,1
realized uponthe receipt,1
represent a recovery,1
were the subject,1
is the applicable local currency,1
using the current exchange,1
ratesfor the period,1
resulting translation,1
perform the qualitative annual assessment,1
include thenature,1
utilizes an incomebased approach,1
requires the company,2
including a risk,1
andor market,1
remained unchangedthe impairment test,1
estimates the fair value,2
believes the relief,1
indefinitelived intangible asset,1
forecasted undiscounted cash,2
using the straightline,3
performs arecoverability assessment,1
located inmemphis,1
concluded thatthe suspension,1
represented an impairment indicator,1
performed a recoverabilityassessment,1
using a method,1
requires recognition,1
assessing the need,1
establish a valuation,1
recognizes the tax,1
sustained uponexamination,1
met the recognition,1
determines the appropriateclassification,1
underlying contractual maturity,1
controlling financialinterest,1
made ifthe structure,1
holds an ownership,1
uses the equity,1
has significant influence generally,1
represents anownership interest,1
deemed the owner,1
total project,1
project the company,1
performs a saleleaseback,1
have continuinginvolvement,1
using the lastin,1
approximates current replacement,1
capitalizes project,1
training maintenance,1
estimated useful liveswhich range,1
recognizes revenue,1
been renderedthe price,1
reports the gross dollar,1
is a principal,1
is the primary obligor,1
bears full risk,1
bears full credit,1
grantsusing a binomial option,1
stocksharebased compensation,1
be issuedthe income,1
warehouse pick pack,1
deliver inventory,1
considering the status,1
andany other pertinent information,1
using a binomial lattice,1
approach the fair value,1
eachreporting period,1
record the impact,1
measured fair value,1
recognizing expense,1
included certain purchase,1
is a leading national provider,1
exceeded the fair value,1
goodwill the fair valueof,1
established a deferred tax,3
acquired customer,1
estimated useful life,4
care tocurrent,1
operating segmentthe purchase,1
pending the finalization,3
working capitaland income,1
represent the final fair,4
values the purchase pricecurrently,1
estimated fair value,13
be deductiblefor income,1
funded the acquisition,1
values the purchase,1
goodwill the fair value,1
held a noncontrolling ownership,1
consolidating the operating,1
consolidate the operating,1
made an additional investment,2
including the noncontrolling interest,1
values the fair value,2
obtaining control,1
theestimated fair value,1
recorded a noncontrollinginterest,1
amortizing the customer,1
estimated fair,1
consolidated shortterm debt,1
0nonrecurring fair value,1
provide future financial support,1
have recourse,1
indicated fiscal year,7
sharebased compensation0,1
address the application,1
have the necessary information,1
provides guidance,1
is complete ii measurement,1
analyzed the income,1
recognized income,1
recorded a deferred income,1
applying a lowerus federal income,1
recorded a current income,1
is net,1
including the impact,1
finalize the measurement,1
reflect the future tax,1
following tax,1
have varyingexpiration,1
carryforwardsin the fiscal year,1
decreased the valuation,1
dueto the utilization,1
recorded this decrease,1
was offsetin part,1
increased the valuation,1
were no tax,1
file income,1
reduced income,1
ending amount,1
excluding interest,1
is asfollows fiscal year,1
made a payment,2
resolve this litigation,1
was an estimate,1
be tax,1
received a private letter,1
recorded a deferred tax,1
recognized a tax,1
represented the estimatedbenefit,1
had a significant impact,1
nonrecurring fair value,1
0revolving credit,1
thingsextend the maturity,1
ranges from0 basis,1
pays facility,1
including compliance,1
has a commercial paper,1
extended the maturity,1
pays a customary unused fee,1
is a financing,1
offers an attractive interestrate,1
has an uncommitted unsecured line,1
provides the company,1
fund shortterm normaltrading cycle,1
rank pari passu,1
incurred inconnection,1
stockholders the repurchase,1
requires compliance,1
consolidated the shortterm,1
have no voting,1
have the exclusive right,1
accumulated other comprehensive loss,1
permitted the company,1
granted theright,1
purchase a minority,1
recognized a reissuance,2
dividing net income,2
considered a related party,1
including a pharmaceutical distribution,1
sponsors various retirement,1
covering eligible employeesthe compensation,1
delegated theadministration,1
approved the termination,1
obtained regulatory approval,1
settle theplan,1
completed the settlement,1
remaining obligation,1
recorded a pension,1
transferred the surplus,1
recorded a charge,1
is a defined contribution,1
investedby the participant,1
recognized anexpense,1
was no discretionary contribution,1
credited servicethe,1
selected keymanagement,1
contributed an amount,1
exceeded the annual compensation,1
compensationto the extent,1
exceeds the annual compensation,2
defer a portion,1
including dividend,1
issued underthe deferred compensation,1
granted option,1
forfeitures the company,1
using a binomial option,1
uses historical exercise,1
granted fiscal year,1
recognized stock,1
presented belowin,1
ofrestricted stock,1
recognized restricted stock,1
nonvested restricted stock,1
recognizing the0,1
recorded rental expense,1
represents thecompanys commitment,1
align the organization,1
accrualsduring the fiscal year,1
salaried defined benefit,1
records a reserve,1
noted the amount,1
recognized a liability,1
predict the outcome,1
permit a private person,1
including the filing,1
requesting production,1
purchasing organization,1
entered a guilty plea,1
paid a total criminal fine,1
resolves the federal criminalinvestigation,1
duly register,1
reached an agreement,1
resolved potentialadministrative action,1
obtained dismissal,1
resolve thecivil litigation,1
making any admission,1
accrued a reserve,1
disclosed matter,1
involving the dispensing,1
had the authority,1
received a subpoena,3
received a grand jury,2
including information generally,1
serve individualswho abuse,1
asettlement agreement,1
including the company,1
includingnegligence public nuisance,1
filed amotion,1
participate i,1
providing information,1
issued an order,1
creating a litigation,1
recommended dismissal,1
recommended thatthe majority,1
oversee courtordered settlement,1
filed suit,1
assess the likely outcome,1
received a request,1
investigating a number,1
regarding this request,1
requesting the production,1
monitoring diversion,2
stored information,1
served an administrative subpoena,1
requesting general information,1
recognized this reserve,1
enact similar legislation,1
regulate the compounding,1
distributing pharmaceutical productsthe,1
dojregarding the ongoing compliance,1
anticipated includingwith regard,1
inoperation an enforcement action,1
andor license revocationnote,1
entering the market,1
named a plaintiff,1
been a member,1
are net,1
require separate reportable segmentdisclosure,1
focus onglobal commercialization,1
operating decision,1
assess the performance,1
represent the elimination,1
incurred remediation,1
assessing performance,1
allocating resourcesthe,1
includes depreciation,1
deferred financing,1
recorded amount,1
includes a loss,1
included discrete income,1
declared a regular quarterlycash dividend,1
maintains disclosure,1
ensure that information,2
required disclosuresthe,1
haveevaluated the effectiveness,1
provide reasonable assurance,5
regarding the reliability,4
reporting andthe preparation,1
thati pertain,1
permit preparation,2
regarding prevention,1
have a material effect,2
deteriorateamerisourcebergens management,1
assessed the effectiveness,1
making this assessment management,1
0during the second quarter,1
registered public accounting,1
issued an attestation,1
ofamerisourcebergens internal control,1
subsidiaries the company,1
conclusionon the effectiveness,1
include an evaluation,1
expressed an unqualified opinion,1
maintaining effective internal control,1
obtaining an understanding,1
assessing the risk,1
evaluating the design,1
operating effectiveness,1
assessed risk,1
provides a reasonable basis,1
companys internal control,1
is a process,1
assuranceregarding prevention,1
including information,5
incorporated herein byreference,1
incorporated herein,4
amended bythe,1
filed onmarch,4
incorporated byreference,8
servicerthe purchaser,1
marked exhibit,1
is a management,1
caused this report,1
contain any untrue statement,2
certifying officer,4
maintaining disclosure,2
designed such disclosure,2
caused such disclosure,2
being prepared b,2
designed such internal control,2
caused such internal control,2
evaluated the effectiveness,2
record process,2
report financial information,2
involves management,2
have a significant role,2
reporting s,2
certify pursuant,2
adopted pursuant,2
respects the financial condition,2
written statement,1
the fiscal year ended,107
share registered,1
the registrant is,3
the registrant is not,1
the registrant was,2
the registrant has,2
this chapter is not,1
growthcompany see,1
filer accelerated filer,1
company o,1
company oif,1
company indicate,1
stock held,1
the following document are,1
this report indicated,1
corporationamerisourcebergen is,1
equipment outsourced,4
research reimbursementand,1
management andpackaging,1
industry are,1
total healthcare expenditures,1
therapy continue,1
addition increased,1
growthwe consider,1
national attention has,1
therapy has,1
anddevelopment is,1
the federal government enacted,1
legislation designed,1
drug costs,1
reformlaw provides,1
industry enhanced,1
strategy is,1
unified way has,1
the genericmarketplace including,1
program based,1
offer valueadded,1
rapid new product launches,1
generic product purchasing,1
pharmacy consulting,1
facility networkincludes,1
field staffing,1
the pharmaceutical supply channel,1
reportable segment distributes,3
pharmaceutical distribution including,3
reportable segment provides,3
providersotherother consists,2
force is,1
care pharmacies,1
the fiscalyear ended,6
supply are,1
fiscal year ended,15
segment operates,1
inventory tracking,1
singlesource billing,1
systemswhich are,1
the warehouse operating,1
providerscompetitionwe face,1
business have,1
registrationwe have,1
supply dispensing,1
marketing compounding,1
decree is,6
any way paid,2
counterfeit diverted,1
legislation known,3
insurance including,1
market reforms,1
insurance mandates,1
regulation governing,1
the interpretationsof existing,1
storage handling,1
andor access protected,1
security breachesbroadened,1
other personal information including,1
personallyidentifiable information is also,1
business are,3
the website are not,1
discussion describes,1
tothose set,1
the government enacts,1
fluctuation based,1
deflation accelerates,1
profitas described,1
section beginning,1
industry has,1
consolidation including,1
andpharmacy compounding,1
pharmaceutical distribution is,1
counterfeitadulterated andor mislabeled,1
regulation impacting,1
cause corresponding,1
form drugsthe,1
program has,1
indication based formulariesthat,1
this trend has,1
prospective system proposed,1
rule published,1
cut is,1
information relating,1
the federalgovernment continues,1
fraud affecting,1
the diversionof controlled,1
the aggregate mayhave,1
legal proceedingswe conduct,1
tam complaints,1
a private person known,2
a relator imposes,1
the litigation proceeds,1
such early termination is,1
flowsthe anticipated,1
agreement including,1
revenue decreased,1
financial resultswe are,1
generic pharmaceutical program has also,1
servicesarrangement does not,1
financial conditionwe are,1
legislation resulting,1
marketing packagingcompounding,1
time investigate,1
iii impose,1
subsidiarywe have,1
the future receive,1
largest0b outsourcing,1
facility located,4
thememphis facility resumes,1
the remediation needed,1
facility andpharmediums,1
temporary licensing suspensionsregarding,1
information concerning,1
our0b outsourcing,1
regulatory authority including,1
business sells,1
safety alert,1
publicity including,1
a classor establish,1
reputational harm resulting,1
death caused,1
litigation risks,1
difficulty finding,1
operationswe are,1
ofacquisition described,1
foreign policy including,1
a substantial amount owed,1
the supplier has,1
online ordering,1
provider does,1
reputation increase,1
damage orunauthorized,1
access remain,1
security measures,1
goodwill indefinitelived,1
relativeto expected,1
ourgoodwill indefinitelived,1
the general economy including,1
business do not,1
following is,4
common stock is,1
other factorscomputershare is,1
the average price paid,1
ofpublicly announced,1
the fiscal yearended,2
repurchase program allowing,8
the company purchased,6
cash settledin,1
availability remaining,5
graph depicts,1
the graph assumes,1
capitalization consists,1
index including,1
share amounts,1
share diluted,1
assessment related,2
of0 millioneincludes,1
hereinwe are,1
reportablesegment provides,2
summary provides,1
gross profit increased,2
facility pending,1
the current fiscal year was negatively,1
systemsoperating income increased,1
the prior fiscal year offset,1
thefiscal year ended,5
charge was,2
rate compared,2
stock vesting,2
the year ended,4
growth trends,1
regulationsrevenue increased,1
segment grew,2
revenue increased,1
group purchasing,2
such customer expires,1
the fiscal year endedseptember,9
remediation costs,4
profit increased,2
the current fiscal year was favorably,1
profit was,1
the current fiscal year was primarily,1
compoundingfacility located,1
each licensee is,2
the increase inrevenue,1
the current fiscal year decreased,2
the prior fiscal year was primarily,5
the priorfiscal year was primarily,1
groupwe recognized,1
expense increased,4
equipment placed,2
annual goodwill impairmentassessmentoperating,1
total segment operating,3
income is,2
income decreased,2
income margindecreased,1
group offset,1
receivable related,2
expense net increased,2
fair values,1
interest see,1
the debt included,1
the prior fiscal yearyear ended,1
gross profit decreased,1
the increase was primarily,1
the priorfiscal yearwe recognized,1
decline compared,1
millioncharge related,1
income was,1
expense acquisitionrelated,1
margin offset,1
operating efficiencyoperating,1
compensation were,2
ruling thatentitled,1
management believes,2
the customer based,1
return trends,1
respectivelyin determining,1
the required allowance requires,2
trade receivables,2
collectability is,1
expense was,2
forany period presented,1
a business are,1
thepurchase price allocated,1
fair value based,2
information obtained,1
impairment test requires,3
thefair value exceeds,2
no further evaluation is,2
no impairment loss is,2
amount exceeds,2
the fair value is,2
company resides,2
structure beginning,2
production processes,2
test requires,1
growth operating,1
rate is,2
return required,2
capital includes,1
equity including,2
method is,4
value derived,1
usewe completed,1
impairment recorded,2
assessment are inherently,3
future periodswe perform,1
activity represented,2
assessment was,2
group excluding,1
group was0,1
expense deferred,1
tobe paid,1
purposeswe have,1
judgment is,1
the positionwe believe,1
paragraphs are,1
this evaluation is,2
an investment is,2
the entitys economicperformance combined,1
aninvestment is not,1
that determination is,2
a loss has,2
the amount is reasonably,1
aloss is either,1
an additional loss has,2
loss has,2
provision is,2
the multicurrency revolving,1
facility thereceivables,1
dollar denominated,1
cash held,1
general corporate purposeswe have,1
balance mayrequire,1
shortterm capital needs,1
shortterm working capital needs,1
the maturity tooctober,1
rating ranging,2
time issue,2
time amounts,2
program does not,2
turn sells,2
sourceswe have,1
note revolving,2
principal payment is,4
the margin is,4
consideration paid,1
arrearswe consolidated,1
debt is,2
thereon is,2
this program inmay,1
program permitted,1
transaction was,2
the financial institution delivered,2
cash settled,2
market conditionsin,1
a sixmonth period beginning,3
repurchase programin,2
the sixmonth period beginning,1
owner see,2
ourliability related,1
tax is,2
asixyear period commencing,1
commitment is,1
arrangement whichexpires,1
this liability represents,1
liability has,1
the timing ofscheduled,1
plus interest see,1
benefit was primarily,1
the result ofapplying,1
net deferred,2
the month ends,1
period based,2
end working capitaladditionally,1
cash flows,2
receivable was,1
various technology initiativesin,1
the cash used,1
cash consolidated,1
cash used,1
common stock offset,1
senior notesnet cash used,1
cash provided,2
programwe used,1
increasesdividend increases,1
the year based,1
cash invested,1
foreign currency denominated forward,1
oneforeign currency denominated,1
thisreport are,1
intend plan continue,1
synergyon track believe,1
generic pharmaceutical pricing including,1
regulatory environment including,1
litigation including,1
facility managing,1
foreign expansion including,1
business generallycertain,1
the period ended,1
schedule listed,1
report dated,2
responsibility is,2
firm registered,1
evidence regarding,1
value authorized,1
translation adjustments,1
torestricted share vesting,3
cash acquired,1
share vesting,1
hasa controlling,1
the quarter ended,3
forrevenue arising,1
principle is,1
the entity expects,1
the adoption had,1
a modified retrospective application is,1
price recorded,1
revenue andrepresented approximately,1
financial conditionand maintains,1
the company records,4
a loss is,1
a losscould be,1
policy prohibits,1
tradingpurposesthe company has,1
foreign currency denominated,1
the weighted average exchange ratesfor,1
the company elected,2
ofwhich is,1
the fair value derived,1
assessment ofprofarmas,1
the company performs,2
group excludinggoodwill,1
group was,1
the company concluded,1
assessment are,1
longterm based,1
the company had,2
impact theentitys economic performance combined,1
an investment is not,1
company uses,1
expense is,2
equipment are,1
maintenance arecharged,1
software developed,1
an arrangement exists,1
renderedthe price is,1
collectability is reasonably,1
risk associated,1
profit earned,1
any year presentedsharebased,1
option grantsusing,1
compensation paid,1
benefitsfrom sharebased,1
appropriate based,1
model approach,1
andthe related,1
an adjustment was,1
hadbeen used,1
expense starting,1
adjustmentspharmedium is,1
price was,1
price exceeded,1
technology is,1
the acquisition are,2
price has,2
the preliminary allocation is,3
the final fair values,4
new longterm debt see,1
the acquisition strengthens,1
the acquisition are not,1
joint venture toincrease,1
joint venture have,1
the noncontrolling interest was,1
the preliminaryallocation is,1
control exceeded,1
the customer relationships,1
the consolidation are not,1
joint venture was,1
percentage acquired,1
theconsolidation are not,1
these represent level 0nonrecurring,1
fair value measurements,1
isnot obligated,1
staff issued,1
a registrant does not,1
the measurement period is,1
a companysaccounting is,1
a sixyear period commencing,2
the company has,4
the fiscal quarter ending,1
information is,1
credit carryforwardsin,1
the company decreased,1
allowance had,1
this decrease was,1
thecompany increased,1
allowance is,1
this amount was not,1
asfollows fiscal year ended,1
position related,1
reserve recognized,1
this reserve was,1
the settlement is,1
the company determined,1
a private letter rulingfrom,1
benefitadjustment had,1
unit was,1
measurementthe following,1
the company entered,4
the company was,2
the company extended,1
the facility is,1
vehicle utilized,1
the company refinanced,1
an additional covenant requires,1
debt are,1
thereafterinterest paid,1
asotherwise provided,1
preferred stock have,1
common stock are,3
repurchase program permitted,1
common stock included,1
common stock received,1
exercisable duringa sixmonth period beginning,1
the sixmonthperiod beginning,1
share is,2
restrictedstock restricted,1
outstanding fiscal year ended,1
stock restricted,2
plan covering,1
an internal committee comprised,1
plan administratorsdefined,1
the company obtained,1
the company completed,1
the company transferred,1
plan coveringsalaried,1
no discretionary contribution recognized,1
this unfunded plan provides,1
keymanagement including,1
compensation exceeded,1
limit established,3
this plan provides,1
total cash compensationto,1
compensation exceeds,1
hercompensation exceeds,1
the amount deferred,1
compensation allocated,1
stock creditsbased,1
each full share credited,1
common stock have,1
liability relating,1
the option is,1
the company estimates,1
model expected,1
expense relating,2
fair value ofrestricted,1
the extent towhich,1
expense associated,1
period ended,1
each participant is,1
the discount provided,1
liability related,1
tax is approximately,1
dispute settlements,1
charge related,1
thecompanys settled,1
a liability has,1
the company has not,1
uncertainty remains,1
litigation arising,1
the case was,1
each purported false claim submitted,1
the complaint is,1
other industry participant,1
these mattersare resolved,1
the guilty plea resolves,1
the federal criminalinvestigation related,1
fiscal quarter ended,1
the reserve was,1
matter involving,1
the laboratory testing,1
diversion ofcontrolled,1
individualswho abuse controlled,1
this matter was,1
theyear ended,1
a motion filed,1
an order creating,1
discovery have,1
the suit be,1
opioid painmedications,1
information requesting,1
a grand jury proceeding,1
additional information related,1
an administrative subpoena requesting,1
the company is,1
the subpoena received,1
matter described,1
the process ofresponding,1
the ability tosuspend,1
class ie,1
chief operating,1
whosefunction is,1
reportable segment operating,1
segment operating,2
itslargest compounding,1
potential resolution ofongoing,1
stability studiesthe,1
resourcesthe following,1
amortization includes,1
expensethe following,1
0total capital expenditures,1
market accounts,1
inputsthe recorded,1
longterm debt see,1
longterm debt was,1
the quarterly dividend paid,1
that information required,2
management haveevaluated,1
such term is,1
theperiod covered,1
the fiscal quarter ended,7
financial reporting is,2
reasonable assurance regarding,5
accounting principles,1
financial reporting includes,2
the company are,1
management assessed,1
this assessment management used,1
management has,1
financial reporting was,2
permittedby related,1
the effectiveness ofamerisourcebergens,1
this report is,3
the company maintained,1
criteriaas indicated,1
financial reporting did not,1
management is,1
financial reporting included,1
financial reporting based,1
a public accounting firmregistered,1
audit included,1
weakness exists,1
internal control based,1
audit provides,1
a process designed,1
thecompany are,1
information appearing,5
this reportwe adopted,1
schedule is,1
trustee related,10
forthe fiscal quarter ended,1
form 0kfiled,2
thefiscal quarter ended,2
buyer dated,1
originator incorporated,2
administrator incorporated,7
asadministrator incorporated,2
recipient incorporated,1
guarantor incorporated,2
the quarter endedmarch,1
administrative agent incorporated,2
v theconsolidated,1
reproductioneach marked,1
exhibit is,1
duly authorized,1
this report has,1
atend ofperiod,1
year ended,2
forthe year ended,1
this report does not,2
the period covered,4
other financial information included,2
material information relating,2
prepared b designed,2
d disclosed,2
the date hereof,2
the information contained,2
all material respects,2
statement required,1
this certification accompanies,1
the extent required,1
